InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Monahan Joseph, Directeur Scientifique. Insider active across 1 company, notably Aclaris Therapeutics, Inc.. In total, 22 reports have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €1.2m. Activity tracked since 9 February 2022. The latest transaction was filed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Monahan Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
50,000 sharesCommon StockSEC:0001415889-25-006495:0
7,500 sharesCommon StockSEC:0001415889-25-002940:0
14,750 sharesCommon StockSEC:0001415889-25-002940:1
11,317 shares@ US$2.482.2% of flowCommon StockSEC:0001415889-25-002940:2
73,750 sharesCommon StockSEC:0001415889-25-000624:0
15,000 shares0Common StockSEC:0001415889-24-029092:0
50,000 sharesCommon StockSEC:0001209191-24-004402:0
7,500 sharesCommon StockSEC:0001209191-24-002840:0
6,000 shares@ US$5.07672.3% of flowCommon StockSEC:0001209191-23-053558:0
6,000 shares@ US$7.31583.3% of flowCommon StockSEC:0001209191-23-046905:0
6,000 shares@ US$10.27714.6% of flowCommon StockSEC:0001209191-23-039070:0
13,750 sharesCommon StockSEC:0001209191-23-016065:0
5,000 shares@ US$13.06215.0% of flowCommon StockSEC:0001209191-23-010658:0
5,000 shares@ US$15.88236.1% of flowCommon StockSEC:0001209191-22-061695:0
5,000 shares@ US$15.98156.7% of flowCommon StockSEC:0001209191-22-054073:0
30,000 shares@ US$16.27660.072% mcap53.5% of flowCommon StockSEC:0001209191-22-025032:0
27,165 shares@ US$15.711531.8% of flowCommon StockSEC:0001209191-22-018501:0
13,750 sharesCommon StockSEC:0001209191-22-015829:0
383 shares@ US$12.68180.4% of flowCommon StockSEC:0001209191-22-008860:0
1,050 sharesCommon StockSEC:0001209191-22-006836:0
2,333 sharesCommon StockSEC:0001209191-21-054530:0
50,000 sharesCommon StockSEC:0001209191-21-037478:0
22 of 22 declarations
About Monahan Joseph
Monahan Joseph is Directeur Scientifique and Chief Scientific Officer at Aclaris Therapeutics, Inc. He has a total of 22 filings, and the filings in the sampled recent set cover the period from 2021-06-02 to 2025-03-04. In the sampled filings, the reported sell amount is EUR 1184220, with no buys indicated, and the most common transaction nature is option exercise.
